| http://www.w3.org/ns/prov#value | - Chiefspants08-15-2010, 08:42 PM...In a joint letter sent to the FDA and key Congressional lawmakers Thursday, Komen for the Cure and the OCNA wrote, We are particularly concerned about patients who are presently receiving bevacizumab and the message that this decision sends about drug development for women with advanced breast cancer.
|
